2p85: Difference between revisions

Revision as of 07:49, 29 July 2008

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:2p85.png

Template:STRUCTURE 2p85

Structure of Human Lung Cytochrome P450 2A13 with indole bound in two alternate conformationsStructure of Human Lung Cytochrome P450 2A13 with indole bound in two alternate conformations

Template:ABSTRACT PUBMED 17428784

About this StructureAbout this Structure

2P85 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

ReferenceReference

Structure of the human lung cytochrome P450 2A13., Smith BD, Sanders JL, Porubsky PR, Lushington GH, Stout CD, Scott EE, J Biol Chem. 2007 Jun 8;282(23):17306-13. Epub 2007 Apr 11. PMID:17428784

Page seeded by OCA on Tue Jul 29 07:49:53 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:2p85.gif|left|200px]]
+{{Seed}}
+[[Image:2p85.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_2p85|  PDB=2p85  |  SCENE=  }}
-'''Structure of Human Lung Cytochrome P450 2A13 with indole bound in two alternate conformations'''
+===Structure of Human Lung Cytochrome P450 2A13 with indole bound in two alternate conformations===
-==Overview==
+<!--
-The human lung cytochrome P450 2A13 (CYP2A13) activates the nicotine-derived procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) into DNA-altering compounds that cause lung cancer. Another cytochrome P450, CYP2A6, is also present in human lung, but at much lower levels. Although these two enzymes are 93.5% identical, CYP2A13 metabolizes NNK with much lower K(m) values than does CYP2A6. To investigate the structural differences between these two enzymes the structure of CYP2A13 was determined to 2.35A by x-ray crystallography and compared with structures of CYP2A6. As expected, the overall CYP2A13 and CYP2A6 structures are very similar with an average root mean square deviation of 0.5A for the Calpha atoms. Like CYP2A6, the CYP2A13 active site cavity is small and highly hydrophobic with a cluster of Phe residues composing the active site roof. Active site residue Asn(297) is positioned to hydrogen bond with an adventitious ligand, identified as indole. Amino acid differences between CYP2A6 and CYP2A13 at positions 117, 300, 301, and 208 relate to different orientations of the ligand plane in the two protein structures and may underlie the significant variations observed in binding and catalysis of many CYP2A ligands. In addition, docking studies suggest that residues 365 and 366 may also contribute to differences in NNK metabolism.
+The line below this paragraph, {{ABSTRACT_PUBMED_17428784}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 17428784 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_17428784}}
 ==About this Structure==
@@ Line 34: / Line 38: @@
 [[Category: P450]]
 [[Category: P450 2a13]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 12:35:09 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 07:49:53 2008''